Results 101 to 110 of about 3,203,982 (133)

Case Report: Efficacy and safety of SGLT2 inhibitors in patients with Alström syndrome: a follow-up report of two siblings from the same family

open access: yesFrontiers in Endocrinology
BackgroundErtugliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, is approved for the glycemic management of patients with type 2 diabetes.
Bingjie Xue   +6 more
doaj   +1 more source

Deletion of ALMS1 (alstrom syndrome 1) enhances salt-sensitive hypertension, and induces insulin resistance and obesity in rats

open access: yes, 2017
The Na/K/2Cl cotransporter NKCC2 mediates NaCl absorption by the Thick Ascending Limb (TAL). Increased NKCC2 activity and apical trafficking are associated with salt sensitive hypertension in rodents and humans.
Ortiz, Pablo A   +4 more
core   +1 more source

Hypertension precedes metabolic syndrome in the alms1 (alstrom syndrome 1) knockout rat

open access: yes, 2018
We previously found that Alstrom syndrome 1 protein (ALMS1) is expressed in the kidney where it regulates thick ascending limb (TAL) NaCl reabsorption by controlling NKCC2 endocytosis.
Ortiz, Pablo A, King-Medina, Keyona N
core  

Common variations in the ALMS1 gene do not contribute to susceptibility to type 2 diabetes in a large white UK population

open access: yes
Aims/hypothesis: Alström syndrome is a rare monogenic disorder characterised by retinal dystrophy, deafness and obesity. Patients also have insulin resistance, central obesity and dyslipidaemia, thus showing similarities with type 2 diabetes.
McCarthy MI   +9 more
core  

Novel Mutations of the ALMS1 Gene in Patients With Alström Syndrome

open access: yesInternal Medicine, 2021
Objective Alström syndrome is an autosomal recessive genetic disease caused by a mutation in the ALMS1 gene. Alström syndrome is clinically characterized by multisystem involvement, including sensorineural deafness, cone-rod dystrophy, nystagmus, obesity, insulin resistance, type 2 diabetes and hypogonadism.
Yucai Chen, Shengnan Wu, Chunmei Wang
exaly   +4 more sources

Common Variations in the ALMS1 Gene Do Not Contribute to Susceptibility to Type 2 Diabetes in a Large White UK Population [PDF]

open access: yesDiabetologia, 2006
Alström syndrome is a rare monogenic disorder characterised by retinal dystrophy, deafness and obesity. Patients also have insulin resistance, central obesity and dyslipidaemia, thus showing similarities with type 2 diabetes. Rare mutations in the ALMS1 gene cause severe gene disruption in Alström patients; however, ALMS1 gene polymorphisms are common ...
Andrew Tym Hattersley   +2 more
exaly   +4 more sources

ALMS1 Regulates TGF-β Signaling and Morphology of Primary Cilia [PDF]

open access: yesFrontiers in Cell and Developmental Biology, 2021
In this study, we aimed to evaluate the role of ALMS1 in the morphology of primary cilia and regulation of cellular signaling using a knockdown model of the hTERT-RPE1 cell line.
Søren T Christensen   +2 more
exaly   +2 more sources

Five novel ALMS1 gene mutations in six patients with Alström syndrome

Journal of Pediatric Endocrinology and Metabolism, 2018
Abstract Background: Alström syndrome is a rare autosomal recessive inherited disorder caused by mutations in the ALMS1 gene. Methods: We describe the clinical and five novel mutational screening findings in six patients with Alström ...
ÖZGÜL, RIZA KÖKSAL   +6 more
openaire   +3 more sources

Non-syndromic retinal dystrophy associated with homozygous mutations in the ALMS1 gene

Ophthalmic Genetics, 2018
Dear Editor,Alstrom syndrome (ALMS; MIM# 203800) is characterized by early onset cone-rod dystrophy (CRD), sensorineural hearing loss, obesity, cardiomyopathy, pulmonary disease, hepatic disease, r...
Alanoud Aldrees   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy